Attached files

file filename
10-K/A - PLATA RESOURCES FORM 10-KA DEC. 31, 2009 - NEXUS BIOPHARMA INCbody_plata10kadec312009.htm
EX-32.2 - CERTIFICATE 18 U.S.C. SECT 1350 P. A. CORANES, CFO - NEXUS BIOPHARMA INCcertsect906coranescfo.htm
EX-31.1 - CERTIFICATE RULE 13A-14A DEXTER CALISO, CEO - NEXUS BIOPHARMA INCcertrule13a14acalisoceo.htm
EX-31.2 - CERTIFICATE RULE 13A14A P.A. CORANES, CFO - NEXUS BIOPHARMA INCcertrule13a14acoranescfo.htm
EX-99.1 - DEPART OF ENVIRO, NAT. RESOURCES AND MINES - NEXUS BIOPHARMA INCdeptofenvionatresourmines.htm


Exhibit 32.1

CERTIFICATE PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report (the “Report”) on the Form 10-KA of Plata Resources, Inc. (the “Company”) for the year ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof, I, Dexter R. Caliso, Chief Executive Officer, President and Director, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 
i.        The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities and Exchange Act of 1934, as amended; and

 
ii      The information contained in this Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date:   January 25, 2011

DEXTER R. CALISO
Dexter R. Caliso
Chief Executive Officer,
President and Director





 
 
-1-